Inventor

Takeshi Oshima

Inventor
Tokyo, JP

Overview

18→
Patents
1988–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
A01KAnimal husbandry6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C12NMicroorganisms or enzymes6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
H01PWaveguides6%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
A61KPreparations for medical, dental or toiletry purposes3%
PatentTitleYear
11,114,732Waveguide non-reflective terminator and waveguide circuit202111,069,949Hollow-waveguide-to-planar-waveguide transition circuit comprising a coupling conductor disposed over slots in a ground conductor20218,951,789'Mammalian artificial chromosome vector comprising human cytochrome P450 gene (cluster) and non-human mammalian animal retaining the same'20157,951,381'Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor'20115,559,109'Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist'19965,556,852'N-acryloylpiperazine compounds'19965,470,851'Thiazolidinecarboxylic acid amide derivatives and their therapeutic uses'19955,369,106'N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists'19945,308,867'Platelet activating factor antagonists, named \"the phomactins\", their preparation and use'19945,192,766'N-acryloylpiperazine derivatives, their preparation and their use as PAF antagonists'19935,153,003'Composition for forming antithrombotic medical appliances'19925,151,529'Platelet activating factor antagonists, named \"the phomactins\" their preparation and use'19925,068,340'Isothiazolyl substituted glycerol derivatives containing phosphate groups'19915,021,444'Thianaphthene derivatives'19914,995,898'Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms'19914,898,862'1,2,4-triazinone derivatives, their preparation and use'19904,847,272'Thianaphthene derivatives'19894,777,184'Prostaglandin derivatives, their preparation and use'1988

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1988–1996Patents assigned to SANKYO CO (12)· patent assignee history
1988–2021Based in Tokyo, JP· patent location history
1991Patents assigned to ISHIHARA MINING & CHEMICAL CO (1)· patent assignee history
1991Based in Shiga, JP· patent location history
1994–1995Based in Hiromachi, JP· patent location history
2011Patents assigned to ARCA BIOPHARMA INC (1)· patent assignee history
2011Based in Maebashi, JP· patent location history
2015Patents assigned to CHROMOCT INC (1)· patent assignee history
2015Based in Gunma, JP· patent location history
2021Patents assigned to MITSUBISHI ELECTRIC CORP (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANKYO CO121988–1996
MITSUBISHI ELECTRIC CORP22021
ARCA BIOPHARMA INC12011
CHROMOCT INC12015
ISHIHARA MINING & CHEMICAL CO11991
Locations
LocationPatentsSpan
Tokyo, JP131988–2021
Hiromachi, JP21994–1995
Gunma, JP12015
Maebashi, JP12011
Shiga, JP11991